Login / Signup

Response to: Correspondence on 'Current myositis clinical trials and tribulations' by Saygin et al .

Didem Can TrabulusVictoria WerthJulie J PaikJin-Kyun ParkMerrilee NeedhamIngrid E LundbergLisa Christopher-Stine
Published in: Annals of the rheumatic diseases (2024)
Keyphrases
  • clinical trial
  • interstitial lung disease
  • phase ii
  • systemic sclerosis
  • open label
  • phase iii
  • rheumatoid arthritis
  • double blind
  • study protocol
  • idiopathic pulmonary fibrosis